Henry Rodriguez, Ph.D., M.S., M.B.A.

Dr. Henry Rodriguez serves as the Founding Director of the Office of Cancer Clinical Proteomics Research and is a member of the Senior Leadership team at the National Cancer Institute, National Institutes of Health. Recently, he served as Assistant Director for Strategic Health and Cancer Science in the Executive Office of the President at the White House.

A cell and molecular biologist with a background in business, Dr. Rodriguez has dedicated his career to advancing biomedical research in both basic and clinical science. Previously, Dr. Rodriguez held multiple roles at the National Institute of Standards and Technology (Department of Commerce), including Founding Director of the Cell and Tissue Metrology Research Group; Health Sciences Program/Policy Analyst in the Office of the Directo; and Principal Investigator in the DNA Technologies Group. Rodriguez leads the National Cancer Institute's direction for multi-omics (proteomics/genomics) strategies in cancer research. During his tenure at the White House, projects included the Cancer Moonshot, ARPA-H, and the modernization of clinical trials. Dr. Rodriguez has authored over 150 original research papers and co-edited a best-selling book on oxidative stress and aging.

Education

• M.B.A., Finance and Management, Johns Hopkins University, Rockville, MD
• Ph.D., Cell and Molecular Biology, Boston University, Boston, MA
• M.S., Biology, Florida International University, Miami, FL
• B.S., Biology/Chemistry, Florida International University, Miami, FL
• A.A., Miami Dade College, Miami, FL
• Fellowships: Scripps Research Institute and City of Hope Cancer Center